Inflammation is a complex response of a body to harmful stimuli and plays important pathological roles in the progress of chronic diseases such as chronic obstructive pulmonary disease, cancers, Alzheimer’s diseases cardiovascular disease, asthma, r...
Inflammation is a complex response of a body to harmful stimuli and plays important pathological roles in the progress of chronic diseases such as chronic obstructive pulmonary disease, cancers, Alzheimer’s diseases cardiovascular disease, asthma, rheumatoid arthritis, multiple sclerosis etc. Controlling chronic inflammation is crucial to human health and a key future preventative and therapeutic target.
The citrus unshiu peel (CUP) has been used in Asian traditional medicine for treatment of cough, asthma, bronchial disorders. The CUP is a rich source of flavanones, as well as many polymethoxylflavones (PMFs), which are very little amounts in other plants.
Thus, the present study, the isolation and identification of the active compounds from the extracts of CUP as inhibitors of NO production in LPS-induced. And we investigated the anti-inflammatory effect and the underlying molecular mechanisms of active compound in LPS-induced RAW264.7 cells. Using the screening of NO production assay from CUP extracts, we isolated type PMFs compounds such as nobiletin (NOB), tangeretin(TAN) and quercetogetin (QUE), isolated from the chloroform layers. These compounds inhibited the NO production in LPS-induced RAW264.7 cells, in a dose-dependent manner. One of compounds, QUE has not been previously reported the biological activities for human health including an anti-inflammatory effect. Therefore, we attempted to unravel the mechanisms of the anti-inflammatory effects of QUE.
We investigated the anti-inflammatory effect and the molecular mechanisms of QUE in LPS-induced RAW264.7 cells. The results, QUE inhibited the production of NO and PGE2 by suppressing the LPS-induced expression of inducible iNOS and COX-2 at both mRNA and protein levels. In addition, QUE suppressed the production of pro-inflammatory cytokines, such as IL-1β, IL-6 and TNF-α. We also evaluated the effects of QUE on the activation of NF-κB. QUE inhibited the translocation of the NF-κB subunit p65 into the nucleus by interrupting the phosphorylation of IκB-α in LPS-induced RAW 264.7 cells. Moreover, we confirmed that the suppression of the inflammatory process by QUE was mediated through the MAPKs pathway based on the fact that QUE significantly decreased p-ERK protein expression in LPS-induced RAW264.7 cells. Taken together, the anti-inflammatory effects of QUE were mediated by the inhibition of the NF-κB and MAPK pathways.
Chronic obstructive pulmonary disease (COPD) is contributed the fourth leading cause of mortality worldwide with cigarette smoke (CS) as the main cause. This disease includes two main phonotypes of chronic bronchitis and emphysema with different physiopathology and symptoms. Emphysema is mainly caused by CS and is characterized by the increase alveolar wall cell death and/or failure of the alveolar wall maintenance. Recent data suggest that chronic inflammation and increased oxidative stress contribute to increased destruction and/or impaired lung maintenance and repair in the pathogenesis of emphysema. There are no therapies available that can either prevent or cure the progression of COPD-emphysema.
Accordingly, the aim of this study is investigate whether mitophagic cell death in CSE-exposed lung bronchial epithelial cells (BEAS-2B), and to confirmed whether or not QUE has inhibitory effects on mitophagy dependent apoptosis in CSE-induced. Firstly, our results demonstrated that CSE induce mitophagy that is associated with a mitochondrial dysfunction and an increase of mitophagy regulator protein expression. The CSE treatment significantly caused the induction of apoptotic indicator and the increase of apoptosis related protein expression levels. To examine whether p-DRP-1 or PINK1, has a role in CSE-induced apoptotic cell death, we knocked down DRP-1 or PINK1 expression by transfecting targeted siRNA in BEAS-2B cells. Consequently, we founded that DRP-1 regulates the activity of caspase-3 by regulating of apoptosis related protein expressions, and subsequently regulates apoptotic indicator such as cell cytotoxicity and viability. Based on these findings, DRP-1 is an essential factor for CSE-induced mitophagy, and it affects the efficiency of apoptosis, suggesting that mitophagy dependent apoptotic pathway may be a therapeutic target for emphysema. Secondly, we tested the effect of QUE on mitophagy dependent apoptotic cell death in CSE–induced BEAS-2B cells. QUE has never been studied in pulmonary diseases. As results that QUE protected against CSE-induced mitochondrial dysfunction and cell death in vitro. QUE inhibited the mitophagy by suppressing the expression levels of p-DRP-1 and PINK1 proteins in CSE-induced BEAS-2B cells. In additional, QUE decreased the expression of apoptosis related proteins, such as cleaved cas-3, -8 and -9. We confirmed that the suppression of the mitophagic cell death by QUE was mediated through the regulation of caspase activity based on the fact that QUE significantly decreased p-DRP1 and PINK1 protein expression in CSE-induced human bronchial epithelial cells.
These findings show that anti-inflammatory and anti-mitophagy dependent apoptotic cell death activities of QUE in vitro, suggesting that QUE may be a therapeutic potential agent in the inflammatory diseases such as COPD-emphysema.